Skip to main reading area
Ipamorelin Injections Field Guide Plain reading notes for patients. Not a clinic or drug shop.

Patient Reading Guide • Field Questions and Studies

Field Questions on Human Trials, Body Fat Claims, and Sport Rules

Ads and blogs often talk about ipamorelin injections as if large human trials proved gains for muscle, sleep, and fat loss. This plain guide walks through what human testers and lab animals saw in the public record. As of October 2026, only 2 clinical studies of ipamorelin in people have ever been published in medical journals.

Calm winter daylight over pale coastal water seen through a frosted glass window
Clear facts help sort sales promises from real human study records.

Common Myth

Myth Versus Fact on Human Trials

Common Claim

Many ads state that human trials prove ipamorelin builds lean muscle, deepens sleep, and slows aging.

Verified Record

In its October 2024 review, the FDA found no clinical study showing ipamorelin works for any medical condition. Neither of the 2 human studies published through October 2026 measured muscle gain, body fat, sleep quality, or aging.

The first human study, published in 1999, gave healthy men a 15-minute drip into a vein. Half of the drug cleared from the blood in about 2 hours, and growth hormone peaked near 40 minutes before fading within 6 hours. In October 2024, the FDA noted that no study has ever measured how under-the-skin injections move through the human body.

The second published human study, reported in 2014, gave vein drips to 114 adults for up to 7 days after bowel surgery. Patients on ipamorelin ate a first meal at 25.3 hours versus 32.6 hours on a dummy drip, a 7-hour difference that could be chance. A larger follow-up bowel trial with 320 patients finished in May 2014, and as of October 2026 its results remain unpublished.

A search of ClinicalTrials.gov in October 2026 shows only 3 entries mentioning ipamorelin, with none testing fat loss or muscle gain. Two sports medicine reviews published in 2026 report that human safety data remain scarce and CJC-1295 combination evidence comes only from animals.

Common Myth

Myth Versus Fact on Fat Loss and Animal Studies

Common Claim

Online ads often call ipamorelin a proven fat-burning and bone-building shot.

Verified Record

In a 2001 mouse study, ipamorelin raised body weight by 15% over 2 weeks and increased body fat pads and food intake. Rat experiments in 1999 and 2000 showed growing bones got longer, while bone density itself did not increase.

Another 2001 study gave adult rats a steroid drug alongside ipamorelin for 3 months and saw stronger muscle tension in those rats. An online seller quoted that rat paper on its sales page, which the FDA cited in an August 24, 2026 warning letter over unapproved drug claims. Results in mice and rats do not show what a drug will do to weight, bone, or muscle in people.

Common Myth

Myth Versus Fact on Sport and Military Rules

Common Claim

Some athletes hear that ipamorelin passes sport and service drug checks since it nudges the body to release its own hormone.

Verified Record

The World Anti-Doping Agency Prohibited Lists effective January 1, 2026 and January 1, 2027 ban ipamorelin by name at all times. The US Department of Defense prohibited supplement list, updated May 26, 2026, also bars service members from using ipamorelin.

Anti-doping scientists published a 2015 method showing that urine tests detect ipamorelin breakdown pieces even after the parent compound clears. Per the US Anti-Doping Agency in September 2026, athletes with a real illness must get a Therapeutic Use Exemption before using a banned drug.

Questions to Ask a Doctor

Ask if any human trial has ever tested the exact shot and goal you are talking about.

If you play tested sports or serve in the military, ask how any care plan fits sport and service rules.

Study Guide

Compare What Was Studied Against What Is Claimed

Use the buttons below to compare human hospital trials, animal lab work, and sport drug rules.

Human Hospital Studies

Only 2 human trials were published through October 2026: a 1999 vein drip study in men and a 2014 bowel surgery trial.

The FDA reported in October 2024 that bowel surgery development stopped after the trial showed no meaningful gut recovery gain.

Animal Lab Tests

Mice given ipamorelin in a 2001 experiment gained 15% body weight in 2 weeks and added extra body fat.

Pig and rat studies between 1998 and 2001 tested hormone bursts, bone length, and steroid weakness, never human wellness.

Sport and Service Bans

World anti-doping rules for 2026 and 2027 prohibit ipamorelin in and out of competition under peptide hormone rules.

Military rules updated May 26, 2026 forbid service members from taking dietary supplements that contain ipamorelin.

Primary Sources for This Page

Every fact on this page comes from these public health, sport, and medical records.